These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [The recent trend of multi-drug resistant Pseudomonas aeruginosa in the field of surgery]. Nakayama I, Yamaji E. Nihon Rinsho; 1991 Oct; 49(10):2373-80. PubMed ID: 1660947 [No Abstract] [Full Text] [Related]
11. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa. Prasad SV, Ballal M, Shivananda PG. Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274 [Abstract] [Full Text] [Related]
12. [Analysis of clinical features and outcome of nosocomial pneumonia caused by Pseudomonas aeruginosa]. Baĭgozina EA. Klin Med (Mosk); 2009 Jan; 87(6):57-9. PubMed ID: 19670720 [Abstract] [Full Text] [Related]
14. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. Gad GF, El-Domany RA, Zaki S, Ashour HM. J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321 [Abstract] [Full Text] [Related]
15. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience. Tennenberg AM, Davis NB, Wu SC, Kahn J. Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306 [Abstract] [Full Text] [Related]
16. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey. Yakupogullari Y, Poirel L, Bernabeu S, Kizirgil A, Nordmann P. J Antimicrob Chemother; 2008 Jan; 61(1):221-2. PubMed ID: 17981831 [No Abstract] [Full Text] [Related]